CLINICAL_TRIALS
trial_result
· 2016-08-10
Clinical Trial Update: A Study of TAS-303 in Female Patients With Stress Urinary Incontinence [Phase 1]
Summary
A Phase 1 study of TAS-303 in women with stress urinary incontinence has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Stress Urinary Incontinence | Phase 1 | Status: COMPLETED